This heat wave would have been virtually unthinkable fifty years ago. A new international study by World Weather Attribution concludes that the current heat in Western Europe would have been “virtually impossible” without climate change and that the likelihood of such extreme heat has increased significantly over the past few decades.
Whaling returns to Iceland following a two year hiatus.
British Prime Minister Keir Starmer wants to ban social media for young people under the age of 16. Gaming and live-streaming platforms will also face stricter rules, in one of the strictest measures worldwide to better protect children online.
Catching Pokémon in your neighborhood? You may have accidentally helped build better military drones.
Google wants to release 32 million mosquitoes in the US. In the scientific program "Debug," a natural bacterium is introduced into male mosquitoes. Those male mosquitoes are then released into the wild with a clear task.
Have you ever wondered how long an airplane can actually stay in the air? And what is the longest commercial flight ever performed? The skies remain a compelling backdrop and aviation continues to evolve and fascinate many of us. European aircraft manufacturer Airbus is aiming to achieve the hitherto impossible with a unique aircraft being developed for Australian airline Qantas Airways. Will the longest flight fade into history books?
A new pill seemed promising because it provided fewer side effects, but apparently did not do what it promised to do. Indeed, too many women turned out to have fallen pregnant anyway.
There has been a breakthrough in the dire situation in which a speleologist found himself in a cave in northern Italy.
Charles de Batz de Castelmore, Count of Artagnan, or simply d'Artagnan is a French musketeer of mythical status. He died at age 62 during the siege of Maastricht in the Disaster Year of 1673, hit by a musket ball in his throat. He led the attack and was considered France's bravest and best musketeer; only the king was above him.
A new pill called "daraxonrasib" has nearly doubled the survival rate of patients with metastatic pancreatic cancer in a large clinical trial. Cancer specialists call this a breakthrough that could fundamentally change the treatment of one of the deadliest cancers.